Accelerate Diagnostics, Inc
AXDXHealthcare · Laboratory Analytical Instruments · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $11.7M | $12.1M | $12.8M | $11.8M | $11.2M | $9.3M |
| Operating income | −$35.3M | −$54.0M | −$62.8M | −$71.6M | −$63.7M | −$72.8M |
| Net income | −$50.0M | −$61.6M | −$62.5M | −$77.7M | −$78.2M | −$84.3M |
| Total assets | $28.6M | $31.4M | $65.0M | $83.0M | $93.4M | $134.4M |
| Total liabilities | $84.6M | $51.3M | $87.3M | $118.1M | $156.2M | $141.8M |
| Equity | −$56.0M | −$19.9M | −$22.3M | −$35.1M | −$62.9M | −$7.4M |
| EPS (diluted) | $-2.15 | $-4.94 | $-7.61 | $-12.59 | $-1.40 | $-1.55 |
| Shares out. | 21.7M | 99.6M | 67.8M | 59.3M | 54.9M | 54.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −301.8%
- Net margin
- −427.8%
- Return on equity
- 89.3%
- Return on assets
- −175.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 296.2%
- Debt / equity
- —
- Book value / share
- $-2.59
- Revenue growth (YoY)
- −3.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -93.13distress
- Accruals / assets
- −90.5%clean
- Beneish M-Score
- -7.22normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 18, 2025
- NT 10-Qmissed a reporting deadline ↗May 16, 2025
- NT 10-Kmissed a reporting deadline ↗Oct 29, 2009
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Apr 30, 2025 | 297,377 | 14.2 | +1.6% |
| Apr 15, 2025 | 292,807 | 4.3 | -18.4% |
| Mar 31, 2025 | 359,040 | 5.0 | -15.6% |
| Mar 14, 2025 | 425,485 | 21.6 | -3.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Bankruptcy or receivership · Completed an acquisition or dispositionAug 18, 2025
- Entered a material agreementJun 4, 2025
- Director / officer changeMay 28, 2025
- Delisting / listing-standard noticeMay 12, 2025
- Entered a material agreement · Bankruptcy or receivership · New financial obligation · Debt acceleration / triggering event · Regulation FD disclosure · Other material eventMay 8, 2025
- Director / officer changeApr 25, 2025
- Director / officer changeApr 15, 2025
- Other material eventMar 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- NT 10-QAug 18, 2025
- 8-KFORM 8-KAug 18, 2025
- 25-NSEJul 21, 2025
- 3OWNERSHIP DOCUMENTJun 25, 2025
- 8-KFORM 8-KJun 4, 2025
- 8-KMay 28, 2025
- NT 10-QMay 16, 2025
- SCHEDULE 13G/AMay 15, 2025
- 8-KFORM 8-KMay 12, 2025
- 8-KFORM 8-KMay 8, 2025
- 3OWNERSHIP DOCUMENTMay 1, 2025
- 10-K/AApr 30, 2025
- 8-KFORM 8-KApr 25, 2025
- 8-KFORM 8-KApr 15, 2025
- 4OWNERSHIP DOCUMENTApr 7, 2025